Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Amelia Ruth Hofstetter

5PUBLICATIONS

34CO-AUTHORS

HaematologyEnvironmental epidemiologyInnate immunityPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Sep 17, 2024

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.

Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner

|Mar 30, 2024

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.

Myra Happe, Amelia R Hofstetter, Jing Wang

|Apr 19, 2023

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.

Alicia T Widge, Amelia R Hofstetter, Katherine V Houser

|Feb 04, 2022

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.

Katherine V Houser, Grace L Chen, Cristina Carter

|Dec 23, 2017

Monitoring bottlenose dolphin leukocyte cytokine mRNA responsiveness by qPCR.

Amelia Ruth Hofstetter, Kirsten C Eberle, Stephanie K Venn-Watson

Pageof 1

Frequent Collaborators

4 joint publications

Katherine V Houser

3 joint publications

Masaru Kanekiyo

3 joint publications

Sarah F Andrews

3 joint publications

Adrian B McDermott

2 joint publications

Rebecca A Gillespie

2 joint publications

Adrian Creanga

2 joint publications

Raffael Nachbagauer

2 joint publications

Peter Palese

2 joint publications

Mike Castro

2 joint publications

Jason G Gall

Frequent Collaborators

4 joint publications

Katherine V Houser

3 joint publications

Masaru Kanekiyo

3 joint publications

Sarah F Andrews

3 joint publications

Adrian B McDermott

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1<sup>-/-</sup> Mice

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1<sup>-/-</sup> Mice

Published on : Oct 17, 2018

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1<sup>-/-</sup> Mice

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1<sup>-/-</sup> Mice

Published on : Oct 17, 2018

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos